Mark D. Morelli - 13 May 2025 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: Director
Issuer ticker: XYL
Reported as of: 13 May 2025
Net transaction value: +$165,009
SEC form: 4
Accepted by SEC: 14 May 2025, 16:16:14 UTC
Prior SEC filing: 03 Mar 2025
Next SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Juliene Patton, by power of attorney for Mark D. Morelli

Key filing fact

Mark D. Morelli filed Form 4 for Xylem Inc. (XYL) on 14 May 2025.

Key facts

This page summarizes Mark D. Morelli's Form 4 filing for Xylem Inc. (XYL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2025, 16:16.

Change

Previous filing in this sequence was filed on 03 Mar 2025.
Current net transaction value: +$165,009.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001411290 Primary reporting owner

Morelli Mark D

Relationship: Director
Address: C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
Signature: /s/ Juliene Patton, by power of attorney for Mark D. Morelli
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $165,009
Shares: +1,300
Change %: +26%
Price: $126.93
Shares after: 6,298
Date: 13 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

Footnote F2

Includes additional shares due to dividend reinvestment.